Question 1

What is Simcere Pharmaceutical (China) known for?

Accepted Answer

In research, Simcere Pharmaceutical (China) stands highest in Health Sciences (#9,106 of 9,902 worldwide), Medicine (#7,937 of 8,541 worldwide) and Life Sciences (#6,061 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology (Oncology is 16.4× its share of world research).

Question 2

How does Simcere Pharmaceutical (China) rank in research?

Accepted Answer

Simcere Pharmaceutical (China) ranks #21,751 of 22,385 institutions worldwide on research quality in 2022-now (#31,329 all time), and #2,431 of 2,481 in China.

Question 3

Who are the top researchers at Simcere Pharmaceutical (China)?

Accepted Answer

Ranked on the quality score, Renhong Tang, Xiaoxuan Wang and Dongsheng Chen lead among researchers whose main affiliation is Simcere Pharmaceutical (China).

Question 4

What are the most cited papers from Simcere Pharmaceutical (China)?

Accepted Answer

The most cited paper from Simcere Pharmaceutical (China) is "Selenium–GPX4 axis protects follicular helper T cells from ferroptosis" (Yin Yao et al., 2021), with 386 citations. Next come "Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells" (227) and "Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial" (222).

Question 5

Which research topics does Simcere Pharmaceutical (China) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Ferroptosis and cancer prognosis.

Question 6

Which keywords describe research at Simcere Pharmaceutical (China)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Immunotherapy, Chemotherapy, Cancer, Tumor Microenvironment, Clinical Trials, Prognostic Factors and Genomic Instability.

Question 7

Which fields of science does Simcere Pharmaceutical (China) work in?

Accepted Answer

In 2022-now, 57% of research at Simcere Pharmaceutical (China) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (5%). It does 2.6× the world's share of Life Sciences.

Question 8

Is Simcere Pharmaceutical (China)'s research output growing?

Accepted Answer

Output in 2022-2025 was 163% higher than in 2018-2021.